COMBINATION OF MARKERS AT THE ESTROGEN- AND VITAMIN D-RECEPTOR GENES OR EQUIVALENTS THEREOF TO PROGNOSE A RESPONSE TO OSTEOPOROSIS THERAPY

摘要

The present invention relates to a method for determining an individual's predisposition to osteoporosis, development of osteoporosis and/or responsiveness to therapy for osteoporosis. The method comprises the step of determining the estrogen receptor genotype and the vitamin D receptor genotype of the individual, thereby determining an individual's predisposition to osteoporosis, development of osteoporosis and/or responsiveness to therapy for osteoporosis.